학술논문

Baseline requirements for novel agents being considered for phase II/III brain cancer efficacy trials: conclusions from the Adult Brain Tumor Consortium’s first workshop on CNS drug delivery
Document Type
article
Source
Neuro-Oncology. 22(10)
Subject
Biomedical and Clinical Sciences
Oncology and Carcinogenesis
Adult
Brain Neoplasms
Clinical Trials
Phase II as Topic
Clinical Trials
Phase III as Topic
Drug Delivery Systems
Humans
Pharmaceutical Preparations
Neurosciences
Oncology & Carcinogenesis
Oncology and carcinogenesis
Language